ATE328881T1 - Tetrahydropyranderivate und ihre verwendung als therapeutika - Google Patents
Tetrahydropyranderivate und ihre verwendung als therapeutikaInfo
- Publication number
- ATE328881T1 ATE328881T1 AT02755343T AT02755343T ATE328881T1 AT E328881 T1 ATE328881 T1 AT E328881T1 AT 02755343 T AT02755343 T AT 02755343T AT 02755343 T AT02755343 T AT 02755343T AT E328881 T1 ATE328881 T1 AT E328881T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- sub
- therapeutics
- replaced
- hydrogen atoms
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 150000003527 tetrahydropyrans Chemical class 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000036407 pain Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0121874.2A GB0121874D0 (en) | 2001-09-10 | 2001-09-10 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE328881T1 true ATE328881T1 (de) | 2006-06-15 |
Family
ID=9921835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02755343T ATE328881T1 (de) | 2001-09-10 | 2002-09-06 | Tetrahydropyranderivate und ihre verwendung als therapeutika |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7265110B2 (de) |
| EP (1) | EP1427723B1 (de) |
| JP (1) | JP2005506329A (de) |
| KR (1) | KR20040045435A (de) |
| CN (1) | CN1578778A (de) |
| AT (1) | ATE328881T1 (de) |
| BR (1) | BR0212454A (de) |
| CA (1) | CA2459464A1 (de) |
| DE (1) | DE60212153T2 (de) |
| ES (1) | ES2263803T3 (de) |
| GB (1) | GB0121874D0 (de) |
| IL (1) | IL160785A0 (de) |
| MX (1) | MXPA04002295A (de) |
| NO (1) | NO20041431L (de) |
| PL (1) | PL368208A1 (de) |
| RU (1) | RU2004110950A (de) |
| WO (1) | WO2003022839A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0121874D0 (en) | 2001-09-10 | 2001-10-31 | Merck Sharp & Dohme | Therapeutic agents |
| GB0217068D0 (en) * | 2002-07-23 | 2002-08-28 | Merck Sharp & Dohme | Therapeutic agents |
| AU2004218228A1 (en) * | 2003-03-07 | 2004-09-16 | Merck Sharp & Dohme Limited | Tetrahydropyran compounds as tachykinin antagonists |
| US11773127B2 (en) * | 2017-11-08 | 2023-10-03 | Washington University | Compounds and methods for treating bacterial infections |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0906315A1 (de) * | 1996-06-21 | 1999-04-07 | MERCK SHARP & DOHME LTD. | Spiro-piperdin-derivate und ihre verwendung als therapeutica |
| CO5150225A1 (es) * | 1999-03-19 | 2002-04-29 | Merck Sharp & Dohme | Derivados del tetrahidropirano y su uso como agentes terapeuticos |
| GB0020721D0 (en) * | 2000-08-22 | 2000-10-11 | Merck Sharp & Dohme | Therapeutic agents |
| GB0121874D0 (en) | 2001-09-10 | 2001-10-31 | Merck Sharp & Dohme | Therapeutic agents |
-
2001
- 2001-09-10 GB GBGB0121874.2A patent/GB0121874D0/en not_active Ceased
-
2002
- 2002-09-06 MX MXPA04002295A patent/MXPA04002295A/es not_active Application Discontinuation
- 2002-09-06 RU RU2004110950/04A patent/RU2004110950A/ru not_active Application Discontinuation
- 2002-09-06 CA CA002459464A patent/CA2459464A1/en not_active Abandoned
- 2002-09-06 EP EP02755343A patent/EP1427723B1/de not_active Expired - Lifetime
- 2002-09-06 DE DE60212153T patent/DE60212153T2/de not_active Expired - Lifetime
- 2002-09-06 JP JP2003526914A patent/JP2005506329A/ja not_active Ceased
- 2002-09-06 WO PCT/GB2002/004085 patent/WO2003022839A1/en not_active Ceased
- 2002-09-06 US US10/488,842 patent/US7265110B2/en not_active Expired - Fee Related
- 2002-09-06 AT AT02755343T patent/ATE328881T1/de not_active IP Right Cessation
- 2002-09-06 BR BR0212454-8A patent/BR0212454A/pt not_active Application Discontinuation
- 2002-09-06 IL IL16078502A patent/IL160785A0/xx unknown
- 2002-09-06 KR KR10-2004-7003573A patent/KR20040045435A/ko not_active Withdrawn
- 2002-09-06 ES ES02755343T patent/ES2263803T3/es not_active Expired - Lifetime
- 2002-09-06 CN CNA028214706A patent/CN1578778A/zh active Pending
- 2002-09-06 PL PL02368208A patent/PL368208A1/xx not_active Application Discontinuation
-
2004
- 2004-04-06 NO NO20041431A patent/NO20041431L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2004110950A (ru) | 2005-04-10 |
| MXPA04002295A (es) | 2004-06-18 |
| EP1427723B1 (de) | 2006-06-07 |
| EP1427723A1 (de) | 2004-06-16 |
| KR20040045435A (ko) | 2004-06-01 |
| US7265110B2 (en) | 2007-09-04 |
| CA2459464A1 (en) | 2003-03-20 |
| JP2005506329A (ja) | 2005-03-03 |
| ES2263803T3 (es) | 2006-12-16 |
| DE60212153T2 (de) | 2007-05-24 |
| IL160785A0 (en) | 2004-08-31 |
| US20040254184A1 (en) | 2004-12-16 |
| PL368208A1 (en) | 2005-03-21 |
| WO2003022839A1 (en) | 2003-03-20 |
| BR0212454A (pt) | 2004-10-19 |
| CN1578778A (zh) | 2005-02-09 |
| DE60212153D1 (de) | 2006-07-20 |
| NO20041431L (no) | 2004-06-01 |
| GB0121874D0 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083114L (no) | Polysykliske indazolderivater som er ERK-inhibitorer | |
| SG159380A1 (en) | Heteroaryl compounds useful as inhibitors of gsk-3 | |
| ATE413388T1 (de) | Muskarin antagonisten | |
| ATE376547T1 (de) | Derivate des indol-typs als p38 kinase inhibitoren | |
| EA200601830A1 (ru) | Ортозамещённые арильные или гетероарильные амидные соединения | |
| AR068813A1 (es) | Derivados de pirazol sustituidos como antagonistas del receptor de androgenos (ar), un agente farmaceutico que los comprende y su uso en el tratamiento del cancer de prostata | |
| IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
| ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
| MX2009002229A (es) | Benzotriazoles como moduladores de cinasas. | |
| CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
| ATE388958T1 (de) | 4'-c-substituierte 2-haloadenosinderivate | |
| TW200621786A (en) | Condensed pyrazole derivatives, their preparation and application in therapeutics | |
| ATE537830T1 (de) | Nicotinamid derivate und ihre verwendung als therapeutika | |
| UA88329C2 (en) | Dna-pk inhibitors | |
| MX2009003073A (es) | Derivado de 2-piridincarboxamida que tiene efecto activador de gk. | |
| DE602004012758D1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
| ATE374773T1 (de) | Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten | |
| ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| DK1765816T3 (da) | Substituerede 1-propinylpiperaziner med affinitet for MGluR5-receptoren til behandling af smertetilstande | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| NO20052182L (no) | Nye forbindelser | |
| TW200420292A (en) | Benzofuran derivative | |
| MXPA06013387A (es) | Nuevos derivados de piridazinona como inhibidores de cdk2. | |
| ATE328881T1 (de) | Tetrahydropyranderivate und ihre verwendung als therapeutika | |
| MX2010008448A (es) | Compuesto de bencilpiperizina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |